Stepan Company Closes New Jersey Surfactants Facility Amid Commodity Market Pressures

U.S.-based surfactants producer implements
Project Catalyst restructuring with multi-site closures and asset
decommissioning.
New
Jersey, United States: Stepan Company announced on
February 23, 2026, the closure of its Fieldsboro, New Jersey surfactants
production site alongside the decommissioning of select assets at facilities in
Millsdale, Illinois, and Stalybridge, United Kingdom, with all actions targeted
for completion by mid-2026. The Fieldsboro closure responds directly to
sustained weakness in commodity surfactants demand, particularly in the laundry
detergent sector. The site produced sulfonation, betaine, and specialty-tolled
products. Simultaneously, Stepan is decommissioning alkoxylation assets at its
Elwood (Millsdale) facility, consolidating production to its new, more
efficient 75,000 tonne-per-year plant in Pasadena, Texas, which commenced
operations in 2025 with both ethoxylation and propoxylation capabilities. The
Stalybridge organics assets face elimination due to elevated operating costs
and decreased utilization rates. The restructuring is integral to Stepan's
Project Catalyst cost-cutting initiative, with expected restructuring charges
ranging from $70 million to $80 million in 2026, of which $52 million to $62
million will materialize in Q1.
According
to Luis E. Rojo, President and CEO, Stephan Company, “Project
Catalyst is a comprehensive plan designed to further optimize our asset base
and create a more productive and agile organization to enable growth. Project
Catalyst is designed to partially offset inflationary pressures and other
headwinds, while enabling us to maintain the resources and flexibility needed
to deliver exceptional service and value to our customers. These anticipated
savings will also support targeted and strategic investments to boost growth
and strengthen Stepan’s competitive edge.”
According to TechSci
Research, Stepan's strategic consolidation reflects broader industry pressures
confronting North American surfactants producers, who face intensifying
competition from lower-cost Asian manufacturers and structural demand shifts in
traditional end markets. The company's decision to shutter multiple facilities
while channeling production to its technologically advanced Pasadena plant
demonstrates a focus on operational efficiency and cost competitiveness rather
than capacity expansion. This rationalization mirrors trends across the
specialty chemicals sector, where manufacturers are prioritizing asset
optimization over geographic diversification. The restructuring, while painful
in the near term with substantial charges, positions Stepan for improved
margins through enhanced utilization rates at more modern facilities. The
surfactants market outlook remains challenging, with persistent overcapacity
likely to trigger additional industry consolidation through 2027.